Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Additional Listing

23 Jun 2009 15:06

RNS Number : 3703U
ViaLogy PLC
23 June 2009
 



ViaLogy plc

("the Company")

Exercise of Options & TVR

The Company has allotted and issued 178,197 ordinary shares of 1 penny each in the capital of the Company following the exercise of options held by a former employee of ViaLogy LLC, the Company's wholly owned subsidiary.

The Company has made application for the 178,197 new ordinary shares of 1 penny each to be admitted to trading on AIM. Admission is expected to occur on 29 June 2009.

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital at the date of this notice consists of 579,165,497 ordinary shares of 1 penny each.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

For further information please contact:

 

ViaLogy plc
 
 
Terry Bond, Chairman - UK & Europe
 

+44 (0) 1235 834734

 

Nominated Advisor (Seymour Pierce)
 
 
Mark Percy
 
+44 (0) 207 107 8000


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISEALKDAESNEFE

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.